All sponsors

Luye Pharma Group Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-33
RECRUITING3
READOUTS ≤12 MONTHS0
Open Luye Pharma Group Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Denosumab
NCT05853354
P3Active, not recruitingOsteoporosis, Postmenopausal3922025-07-30
LPM3770164 sustained release tablet 5 mg
NCT06731868
P1/2RecruitingTardive Dyskinesia (TD)1202025-10-31
LY01021
NCT07236476
P2Active, not recruitingAssisted Reproduction902025-12-31
Lurbinectedin
NCT06496048
P3RecruitingRelapsed Small Cell Lung Cancer1802027-12-31
LY03020
NCT07396870
P2Not yet recruitingSchizophrenia1602027-12-31
Irinotecan hydrochloride liposome Injection
NCT06128837
P3RecruitingRelapsed Small Cell Lung Cancer6862028-06
LPM6690176
NCT07391566
P1/2Not yet recruitingMetastatic Colorectal Cancer (mCRC)992028-12-31